Graves’ Disease causes hyperthyroidism (overactive thyroid gland), weight loss, anxiety & fatigue. Find out more about the causes of Graves’ Disease, associated health issues, and treatments.
It is caused by thyroid stimulating immunoglobulins (TSI), also known as thyroid stimulating antibodies (TSAb) or thyroid receptor antibodies (TRAb). These antibodies impersonate thyroid stimulatory hormone (TSH) normally produced by the pituitary gland, stimulating the production of thyroid hormones T4 and T3 .
Thyroid hormones affect pretty much all other organs in the body by adjusting how fast metabolism works. That’s why symptoms associated with Graves’ disease can be many and diverse. Common signs and symptoms include [2, 4]:
- Weight loss
- Anxiety and irritability
- Increased heart rate
- Sensitivity to heat
- Enlarged thyroid gland (swollen neck)
- Irregular periods
- Eye pain and redness
- Swollen and protruded eyeballs (Graves’ ophthalmopathy)
- Thick, red skin on the shins or feet (Graves’ dermopathy)
- Dermopathy (skin disease)
These symptoms are not unique, many other conditions can cause them. If you are experiencing any of these symptoms, work with your doctor as soon as possible to get an accurate diagnosis.
Seek immediate care if you’re experiencing heart-related symptoms or vision loss!
To help diagnose Graves’ disease, doctors will look at a number of things, including your signs and symptoms and blood tests, including :
People with Graves’ disease usually have high levels of thyroid hormones (T4 and T3) and low levels of thyroid stimulating hormone (TSH) .
If needed, your doctor can also check :
- levels of antibodies that cause Graves’ disease (TRAb test)
- radioactive iodine uptake
- if the thyroid gland is enlarged by ultrasound or imaging tests (CT, MRI)
Specific immunoglobulins (IgG antibodies), called thyroid stimulating immunoglobulin (TSI), thyroid stimulating antibodies (TSAb), or thyroid receptor antibodies (TRAb), bind to and activate the thyroid stimulating hormone (TSH) receptor on thyroid gland cells. This causes thyroid gland cell growth, which results in an enlarged thyroid and high thyroid hormone levels .
- A family history of Graves’
- Female gender
- Being under 40
- Having other autoimmune disorders (e.g. type 1 diabetes, rheumatoid arthritis)
- Emotional or physical stress, such as stressful events or serious illness, may act as triggers
- Pregnancy and recent childbirth
The overall prevalence of hyperthyroidism in the US is around 1.2% with an incidence of 20/100,000 to 50/100,000. Some data suggest its lifetime risk in women and men is 3% and 0.5%, respectively .
This condition occurs in about a third of people who have Graves’ disease. It’s an eye disease that causes the eye to protrude and the eyelids to retract and lag when opening or closing. T cells (white blood cells) in the body attack an antigen (a molecule that causes an immune response) in the eyes. This leads to swelling and eyeball protrusion .
People with this condition usually have a sandy sensation in their eyes, blurry vision, infrequent blinking, dry eyes, and irritation .
Grave’s ophthalmopathy can, in some cases, occur without hyperthyroidism.
Dermopathy is a skin condition that causes the skin to become red and thick, resembling that of an orange .
This manifestation is relatively uncommon.
In pregnant women with Graves’ disease, the antibodies can cross the placenta and also cause thyroid dysfunction in the fetus .
Because Graves’ is an autoimmune disease, it can be problematic during the early stages of pregnancy. However, during pregnancy, the immune system is suppressed and Graves’ can improve .
If hyperthyroidism and Graves’ is unmanaged, it can cause problems such as :
- High blood pressure
- Heart failure
- Premature birth
- Fetus abnormalities
Studies suggest that people with Graves’ disease may have a higher risk of certain cancers than healthy people. In a meta-analysis of 33 studies, Graves’ disease doubled the risk of getting thyroid cancer .
Additionally, in a cohort study of 25,000 patients, those with Graves’ had a higher risk of developing head and neck, liver, breast, prostate, and thyroid cancer .
Unlike Graves’, Hashimoto’s occurs when an antibody blocks TSH hormone activity and causes damage to the thyroid gland.
After discontinuing antithyroid treatment for 5 – 10 years, 15 – 20% of people that recover from Graves’ can develop hypothyroidism due to Hashimoto’s. Although the exact cause is unknown, researchers think that antithyroid medication may contribute .
Scientists found that one autoimmune disease often increases the risk of getting another. In other words, people whose immune system malfunctions and attacks a certain tissue is more likely to then similarly malfunction and attack other tissues .
In a study (cross-sectional) of 3200 UK thyroid patients, around 10% of people with Graves’ also had another autoimmune disorder, such as :
- Rheumatoid Arthritis
- Type 1 diabetes
- Pernicious anemia
- Celiac disease
- Vitiligo (loss of skin color)
One exception is an autoimmune disease called myasthenia gravis which very rarely occurs together with Graves’disease. Scientists are not yet certain why, but they think it may be because both diseases require a similar mechanism involving Th17 cells .
It’s important to work with your doctor to treat Grave’s disease as soon as possible. Untreated hyperthyroidism can have serious negative consequences. Your doctor will help zero in on a treatment that’s right for you.
Radioactive Iodine (RAI) therapy uses radioactive iodine and can either be used after antithyroid medication or as the initial treatment for Graves’ and hyperthyroidism. RAI works by getting into overactive thyroid cells and destroying enough thyroid tissue to lower thyroid hormone levels [16, 4].
Although RAI is relatively safe, pregnant women should not undergo RAI because it can damage the fetus. Additionally, RAI may worsen Grave’s ophthalmopathy and increases the risk of hypothyroidism (low thyroid hormone levels) .
Propylthiouracil and methimazole are two antithyroid medications that help treat Graves’. They block the production of thyroid hormones .
However, since they mainly inhibit thyroid hormone production and do not address the cause of the disease, patients can experience a high rate of disease recurrence .
While antithyroid medications are generally well-tolerated, their side effects also include stomach problems, muscle pain, and rashes. They might also cause agranulocytosis, or extremely low count of specific white blood cells .
Methimazole has fewer side effects than propylthiouracil, which can potentially cause liver disease and failure .
Propylthiouracil is preferred in the first trimester of pregnancy because methimazole has a slight risk of birth defects .
Studies suggest that better long-term results are achieved when the therapy lasts for over a year.
Beta-blockers are drugs that help reduce high blood pressure or treat heart problems. Using beta-blockers can help rapidly relieve some hyperthyroid symptoms, such as increased heart rate. However, they have no effect on thyroid hormone levels .
Doctors usually recommend removing the thyroid or parts of the thyroid (thyroidectomy) if other treatments were unsuccessful, unsafe, or if the patient cannot undergo other treatments. Additionally, removing the thyroid can provide quick results in comparison to other therapies .
Pregnant women can undergo thyroid removal surgery to prevent damage to their fetus from antithyroid medication or RAI .
Patients who undergo thyroid removal surgery for Graves’ disease have a risk for bleeding and nerve injury. They are also at risk for hypothyroidism (low thyroid hormone levels) after the procedure [19, 17].
Although these new treatments are promising alternatives to the three main therapies, no human clinical trials are available at the moment. It may take several years until these treatments are proven effective and safe in humans. We’ll keep you posted.
Monoclonal antibodies (Mabs) are made in laboratories from human immune cells and can help detect and/or stop harmful antibodies. One such Mab, can block thyroid-stimulating antibodies and may be able to prevent the effect on thyroid in Graves’ disease .
- Glucocorticoids, that can decrease inflammation
- Other immunosuppressants, such as cyclosporine
- Orbital decompression surgery, may help the eyes return to their original position, usually done when the pressure on the optic nerve endangers vision
- Corrective surgery for eyelid retraction and restrictive myopathy
Symptoms of Grave’s ophthalmopathy don’t necessarily improve with treatment for Grave’s disease. They may get worse for a couple of months before they start gradually getting better.
Three things you can do, in addition to treatment, that will help improve your symptoms and improve your health in general are:
- Eating a healthy, well-balanced diet
- Regular exercise
- Avoiding or managing stress. Remember stress can trigger or worsen Graves’ disease.
Avoid foods high in iodine, such as seaweed, and iodine-containing supplements. They may worsen hyperthyroidism. Work with your doctor to figure out what foods and supplements you should avoid.
Few supplements have been studied in humans regarding their effects on hyperthyroidism. Discuss the following supplements with your doctor.
Remember, these supplements may improve symptoms, but won’t address the cause of the disease! None of these supplements should ever be done in place of what your doctor recommends or prescribes!
Always speak to your doctor before taking any supplements, because they may interfere with your health condition or your treatment/medications!
Studies suggest that L-carnitine may be beneficial in improving symptoms such as nervousness, fatigue, and irregular heartbeat .
An initial study of 40 hyperthyroid patients (including 30 people with Graves’disease) found that glucomannan when taken with antithyroid medication, reduced thyroid hormones more than antithyroid medication alone. However, the effect tended to disappear after about 6 weeks of therapy .
Some scientists are of the opinion that this herbal remedy may serve as an alternative for antithyroid medication.
In a study (clinical trial) of 22 Graves’ patients, published in 2008, AJBHT reduced T3 and T4 levels while it increased TSH .
However, there have been no other human studies since to confirm this finding, nor studies that look into long-term effectiveness and safety of this herbal mixture.
A combination of environmental and genetic factors affect a person’s risk for Graves’ disease. We know that because people who have a close relative with Graves’, have a higher chance of getting the disease .
Research suggests that the HLA genes may play an especially important role in Graves’. Although the exact mechanisms are unknown, there are some variants that have been associated with a higher risk of getting Graves’, such as DRB1*03 (in Whites and Blacks) and DPB1 (in Asians) .
- rs2476601 (PTPN22)
- rs1883832 (CD40)
- rs231775 (CTLA4)
- rs3087243 (CTLA4)
- rs2268458 (TSHR)
- rs2239610 (TSHR)
- rs7528684 (FCRL3)
- rs3761959 (FCRL3)
- rs11264798 (FCRL3)
- rs10489678 (FCRL3)
- rs1368408 (SCGB3A2)
- rs41295061 (IL2RA)